# Jones Hill Capital LP: Form 13F holdings

An institutional investment manager in NEW YORK, NY. SEC CIK 2102314.

- Quarter ended: 2026-06-30
- Filed: 2026-08-13
- Reported value: $470.4m
- Positions: 29 (29 lines in the filing's table; lines for the same security and option type are added together here)
- Compared with: the 13F for the quarter ended 2026-03-31
- Filing: https://www.sec.gov/Archives/edgar/data/2102314/000210231426000005/

## Holdings

As filed, largest first. Reported value is what the manager stated at the quarter end (Jun 30, 2026), in US dollars; it is filing data, not a price. Weight is the share of the total reported value.

| Issuer | Class | Reported value | Weight | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | ---: | --- | --- |
| [BIOMARIN PHARMACEUTICAL INC (BMRN)](/companies/bmrn.md) | COM | $81.9m | 17.4% | 1,431,590 |  | Added +163,200 |
| [GILEAD SCIENCES INC (GILD)](/companies/gild.md) | COM | $43.3m | 9.2% | 343,043 |  | New +343,043 |
| [ARCUTIS BIOTHERAPEUTICS INC (ARQT)](/companies/arqt.md) | COM | $28.6m | 6.1% | 1,089,701 |  | New +1,089,701 |
| [MADRIGAL PHARMACEUTICALS INC (MDGL)](/companies/mdgl.md) | COM | $28.2m | 6.0% | 52,545 |  | New +52,545 |
| [BICARA THERAPEUTICS INC (BCAX)](/companies/bcax.md) | COM | $26.5m | 5.6% | 892,621 |  | Reduced −367,515 |
| [RELMADA THERAPEUTICS INC (RLMD)](/companies/rlmd.md) | COM | $25.3m | 5.4% | 3,655,075 |  | Added +3,312,323 |
| [TREVI THERAPEUTICS INC (TRVI)](/companies/trvi.md) | COM | $25.0m | 5.3% | 1,339,212 |  | Added +969,037 |
| PHARVARIS N V | COM | $23.4m | 5.0% | 677,879 |  | Added +510,865 |
| [XENON PHARMACEUTICALS INC (XENE)](/companies/xene.md) | COM | $22.2m | 4.7% | 367,900 |  | New +367,900 |
| [ANI PHARMACEUTICALS INC (ANIP)](/companies/anip.md) | COM | $19.4m | 4.1% | 233,808 |  | Reduced −84,783 |
| [IMMUNOCORE HLDGS PLC (IMCR)](/companies/imcr.md) | ADS | $16.3m | 3.5% | 512,856 |  | New +512,856 |
| [AMYLYX PHARMACEUTICALS INC (AMLX)](/companies/amlx.md) | COM | $16.1m | 3.4% | 894,058 |  | Reduced −704,736 |
| [INSMED INC (INSM)](/companies/insm.md) | COM PAR $.01 | $13.0m | 2.8% | 122,375 |  | New +122,375 |
| NUVALENT INC | COM | $12.2m | 2.6% | 98,442 |  | Reduced −202,388 |
| [CAPRICOR THERAPEUTICS INC (CAPR)](/companies/capr.md) | COM NEW | $10.1m | 2.2% | 420,751 |  | Reduced −488,456 |
| [ACLARIS THERAPEUTICS INC (ACRS)](/companies/acrs.md) | COM | $9.3m | 2.0% | 1,759,492 |  | New +1,759,492 |
| [IMMUNIC INC (IMUX)](/companies/imux.md) | COM NEW | $8.3m | 1.8% | 539,814 |  | New +539,814 |
| [ORIC PHARMACEUTICALS INC (ORIC)](/companies/oric.md) | COM | $8.1m | 1.7% | 747,313 |  | New +747,313 |
| [TONIX PHARMACEUTICALS HLDG C (TNXP)](/companies/tnxp.md) | COM NEW | $8.0m | 1.7% | 625,428 |  | Added +173,312 |
| [SYNDAX PHARMACEUTICALS INC (SNDX)](/companies/sndx.md) | COM | $7.4m | 1.6% | 340,000 |  | New +340,000 |
| [OLEMA PHARMACEUTICALS INC (OLMA)](/companies/olma.md) | COM | $7.2m | 1.5% | 574,166 |  | New +574,166 |
| [VIR BIOTECHNOLOGY INC (VIR)](/companies/vir.md) | COM | $6.7m | 1.4% | 659,213 |  | Reduced −539,000 |
| [CORBUS PHARMACEUTICALS HLDGS (CRBP)](/companies/crbp.md) | COM NEW | $6.1m | 1.3% | 653,572 |  | New +653,572 |
| [DIANTHUS THERAPEUTICS INC (DNTH)](/companies/dnth.md) | COM | $5.6m | 1.2% | 57,100 |  | New +57,100 |
| [VERTEX PHARMACEUTICALS INC (VRTX)](/companies/vrtx.md) | COM | $5.5m | 1.2% | 11,123 |  | Reduced −97,480 |
| [ENLIVEN THERAPEUTICS INC (ELVN)](/companies/elvn.md) | COM | $2.5m | 0.5% | 49,850 |  | Reduced −543,190 |
| [STRUCTURE THERAPEUTICS INC (GPCR)](/companies/gpcr.md) | SPONSORED ADS | $2.2m | 0.5% | 40,567 |  | Reduced −60,026 |
| [PHATHOM PHARMACEUTICALS INC (PHAT)](/companies/phat.md) | COM | $1.8m | 0.4% | 161,486 |  | New +161,486 |
| [ACHIEVE LIFE SCIENCE INC (ACHV)](/companies/achv.md) | COM | $174.7k | <0.1% | 26,760 |  | New +26,760 |

## Sold out

Held at the end of the quarter before and not reported this quarter.

| Issuer | Class | Reported value | Weight | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | ---: | --- | --- |
| [ARGENX SE (ARGX)](/companies/argx.md) | SPONSORED ADR | $0 | 0.0% | 0 |  | Sold out −25,995 |
| [ARRIVENT BIOPHARMA INC (AVBP)](/companies/avbp.md) | COM | $0 | 0.0% | 0 |  | Sold out −45,809 |
| [CONTINEUM THERAPEUTICS INC (CTNM)](/companies/ctnm.md) | CL A | $0 | 0.0% | 0 |  | Sold out −513,053 |
| [ENTRADA THERAPEUTICS INC (TRDA)](/companies/trda.md) | COM | $0 | 0.0% | 0 |  | Sold out −374,010 |
| [FULCRUM THERAPEUTICS INC (FULC)](/companies/fulc.md) | COM | $0 | 0.0% | 0 |  | Sold out −1,771,926 |
| [NUVATION BIO INC (NUVB)](/companies/nuvb.md) | COM CL A | $0 | 0.0% | 0 |  | Sold out −2,383,031 |
| [ORUKA THERAPEUTICS INC (ORKA)](/companies/orka.md) | COM | $0 | 0.0% | 0 |  | Sold out −140,843 |
| [SILENCE THERAPEUTICS PLC (SLN)](/companies/sln.md) | ADS | $0 | 0.0% | 0 |  | Sold out −301,604 |
| TERNS PHARMACEUTICALS INC | COM | $0 | 0.0% | 0 |  | Sold out −521,237 |
| [ULTRAGENYX PHARMACEUTICAL IN (RARE)](/companies/rare.md) | COM | $0 | 0.0% | 0 |  | Sold out −1,165,557 |
| [VAXCYTE INC (PCVX)](/companies/pcvx.md) | COM | $0 | 0.0% | 0 |  | Sold out −644,831 |
| [VERADERMICS INC (MANE)](/companies/mane.md) | COMMON STOCK | $0 | 0.0% | 0 |  | Sold out −100,843 |

Source: SEC EDGAR, Form 13F-HR, accession 0002102314-26-000005. Last ingested by Listed: Oct 22, 2026, 05:26 ET. No prices; not investment advice.